Showing results (1281-1290 of 3,791) with videos related to
Sort By:
Pageof 380
Oncoimmunology|December 18, 2012
Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatmentAdriana J Michielsen, Elizabeth J Ryan, Jacintha N O'SullivanOncoimmunology|December 18, 2012
Immunotargeting of tumor subpopulations in melanoma patients: A paradigm shift in therapy approachesMargarita Maurer, Rajasekharan Somasundaram, Meenhard Herlyn, et al.Oncoimmunology|December 25, 2012
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophanRichard Metz, Sonja Rust, James B Duhadaway, et al.Oncoimmunology|December 25, 2012
Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destructionSabrina Danilin, Alyssa R Merkel, Joshua R Johnson, et al.Oncoimmunology|December 25, 2012
A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cellsMadhusoodhanan Rakhesh, Moriasi Cate, Ramani Vijay, et al.Oncoimmunology|December 25, 2012
Immunization with a prostate cancer xenoantigen elicits a xenoantigen epitope-specific T-cell responseLaura E Johnson, Thomas P Frye, Douglas G McNeelOncoimmunology|December 25, 2012
Immunotherapy of acute myeloid leukemia based on γδ T cellsJulie Gertner-Dardenne, Cyril Fauriat, Norbert Vey, et al.Oncoimmunology|December 25, 2012
Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodiesInge Verbrugge, Mara Galli, Mark J Smyth, et al.Oncoimmunology|December 25, 2012
Radiation and immunotherapy: Renewed allies in the war on cancerSteven K Seung, Brendan Curti, Marka Crittenden, et al.Oncoimmunology|December 25, 2012
Emerging evidence of anti-tumor immune control in the central nervous systemAndrew M Donson, Nicholas K ForemanPageof 380